Loading…
Based on limited metadata with no full letter text available, this FDA Warning Letter issued in April 2019 concerns Nationwide Laboratories, LLC, a company involved in drug manufacturing or distribution. While the specific violations cannot be detailed without access to the complete letter, the warning was issued under FDA's drug product authority. Additional context regarding the issuing office and specific violation count would be needed to fully characterize the regulatory concerns and their scope.